...
首页> 外文期刊>Medicine. >What are the mechanisms of action of anti-inflammatory agents in adipose tissue?
【24h】

What are the mechanisms of action of anti-inflammatory agents in adipose tissue?

机译:脂肪组织中抗炎剂的作用机制是什么?

获取原文

摘要

BACKGROUND:Obesity is a disease characterized by the abnormal accumulation of adipose tissue in the body, triggering a chronic subclinical state of inflammation. Bioactive compounds, given their anti-inflammatory properties, are a safe and promising alternative in controlling the inflammatory condition of obesity. This study describes a systematic review protocol aiming to analyze the anti-inflammatory molecules mechanisms and compounds action on adipocytes.METHODS:Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA-P) will outline the protocol and PRISMA to the systematic review. The databases used for research will be PubMed, Science Direct, Scopus, Web of Science, BVS, and EMBASE. Experimental studies performed on rats and mice with a control group that describes treatment with anti-inflammatory agents (drugs, nutraceuticals, bio active compounds, among others) at any frequency, time, and dose will be included. Three independent reviewers will select studies and extract data. The evaluation of the methodological quality of each research will be performed using the SYRCLE tool. If at least 2 studies show clinical and/or methodological and/or statistical homogeneity, a meta-analysis will be performed, using the RevMan Analyzes statistical package in Review Manager v.5.3.RESULTS:In this study, we hope to find a considerable number of articles presenting mechanisms involved in the action of anti-inflammatory molecules and compounds on adipocytes.CONCLUSION:The systematic review produced from this protocol will present evidence on the mechanisms involved in the action of anti-inflammatory molecules and compounds in adipocytes. It will also contribute to developing new research and new insights about anti-inflammatory therapies with a future application view.RECORD OF SYSTEMATIC REVIEW:This review was registered with the International Register of Prospective Systematic Reviews on May 18, 2020 (registration: CRD42020182897). Available at: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42020182897.Copyright ? 2021 the Author(s). Published by Wolters Kluwer Health, Inc.
机译:背景:肥胖是一种疾病,其特征在于体内脂肪组织的异常积聚,引发慢性亚临床炎症状态。鉴于其抗炎性质,生物活性化合物是控制肥胖症的炎症状况的安全和有希望的替代方案。本研究描述了一种系统审查方案,其旨在分析抗炎分子机制和化合物作用对adipocytes.方法:系统审查和Meta-Analysis议定书(Prisma-P)的首选报告项目将概述系统审查的议定书和PRISMA 。用于研究的数据库将是PubMed,Science Direct,Scopus,科学网站,BVS和Embase。在任何频率,时间和剂量中,用对照组对具有对照组进行的对照组进行的实验研究,其将在任何频率,时间和剂量中包含抗炎剂(药物,营养品,生物活性化合物等)。三名独立审阅者将选择研究和提取数据。将使用斜束工具进行每个研究的方法质量的评估。如果至少2个研究表明临床和/或方法和/或统计均匀性,则使用Revman分析统计包的审查经理V.5.3.Results:在本研究中,我们希望找到相当大的提出涉及抗炎分子和化合物对脂肪细胞的作用的机制的数量。结论:从本协议产生的系统审查将提出有关抗炎分子和脂肪细胞中的化合物作用的机制的证据。它还将有助于开发关于抗炎疗法的新研究和新的见解,通过未来的应用程序观点。系统评价的重点是:这条评论是在2020年5月18日(注册:CRD42020182897)的国际未来系统评论中注册的。可用:https://www.crd.york.ac.uk/pospero/display_record.php?id=crod42020182897.copyright? 2021提交人。由Wolters Kluwer Health,Inc。出版

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号